메뉴바로가기 본문바로가기

SDB MEDIA CENTER

This is the main news of SD BIOSENSOR.

Company news

  • No. 82
  • Notice
82.US$21 Million Investment Brings Molecular Diagnostic Testing for COVID-19 and Other Infectious Diseases Closer to Patients in LMICs
  • Date 2021.12.22
  • views 6,311
82.US$21 Million Investment Brings Molecular Diagnostic Testing for COVID-19 and Other Infectious Diseases Closer to Patients in LMICs
  • Notice 2021.12.22
  • 6,311

  • FIND, the global alliance for diagnostics, announced an investment of US$21 million to accelerate the development, manufacturing, and launch of affordable, multi-pathogen, molecular diagnostic platforms, specifically for use in decentralized settings in low- and middle-income countries (LMICs). Following an open call for partners and a competitive selection process, four companies with promising new platforms have been selected for investment: Biomeme, Inc (USA), Bioneer Corporation (Republic of Korea), Qlife Holding AB (Sweden) and SD Biosensor, Inc (Republic of Korea).

    Please visit FIND for more information.
    https://www.finddx.org/newsroom/pr-20dec21/
List
Top